Brief: TELA Bio Q3 Revenue USD 15.052 Million Vs. IBES Estimate USD 16.2 Million
09/11/2023 21:05
Nov 09 (Reuters) - TELA Bio Q3 gross profit USD 10.389 million. * Q3 income from operations USD -10.181 million * Q3 operating expenses USD 20.57 million * Q3 basic EPS USD -0.45 * Q3 net income USD -10.957 million * outlook FY revenue USD 57-60 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants